Skip to main content
Terry Kim, MD, Ophthalmology, Durham, NC

TerryKimMD

Ophthalmology Durham, NC

Cataract Related, Cornea & External Disease

Professor of Ophthalmology, Duke University School of Medicine

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

  • Office

    Duke Medical Ctr
    # 3802
    Durham, NC 27710
    Phone+1 919-681-3568
    Fax+1 919-660-5070

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineResidency, Ophthalmology, 1993 - 1996
  • California Pacific Medical Center
    California Pacific Medical CenterInternship, Internal Medicine, 1992 - 1993
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1992

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1997 - 2025
  • PA State Medical License
    PA State Medical License 1996 - 1998
  • GA State Medical License
    GA State Medical License 1993 - 1997
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Top MD Consumers Checkbook
  • Fellow (FAAO) American Academy of Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • Avellino Labs Expands Medical Advisory Board with Internationally-Renown Ophthalmologists
    Avellino Labs Expands Medical Advisory Board with Internationally-Renown OphthalmologistsApril 29th, 2019
  • Eyenovia to Participate in Panel Presentation at OSN New York 2018
    Eyenovia to Participate in Panel Presentation at OSN New York 2018September 19th, 2018
  • Kala Pharma Wins FDA Nod for Twice-Daily Ocular Corticosteroid
    Kala Pharma Wins FDA Nod for Twice-Daily Ocular CorticosteroidAugust 24th, 2018
  • Join now to see all

Professional Memberships